Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29722800 | 1.00 | ALDH1A1 (0.48) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| Piperidine SCHEMBL8531626 | 0.87 | ADRA2A (0.40) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| SCHEMBL3257274 | 0.85 | TLR2 (0.40) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| SCHEMBL16456192 | 0.85 | TLR2 (0.44) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| SCHEMBL6906070 | 0.85 | SRC (0.41) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| SCHEMBL24605381 | 0.83 | ERN1 (0.58) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| SCHEMBL3381150 | 0.83 | ERN1 (0.39) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| SCHEMBL30772183 | 0.83 | ERN1 (0.39) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| SCHEMBL24631749 | 0.83 | ALDH1A1 (0.40) | ALDH1A1HPGDHTTSMN1; SMN2LMNA | |
| SCHEMBL30748252 | 0.83 | ALDH1A1 (0.40) | ALDH1A1HPGDHTTSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112920039-A | Diarylacetylene compound containing methylene quinone, preparation method and application thereof | 大连理工大学 | 2021-06-08 | — | — | CN | claimed |
| EP-0511917-B1 | Glycosylated prodrugs, process for their preparation and uses thereof | HOECHST SA LAB (FR) | 1996-10-23 | — | — | EP | claimed |
| JP-3077872-A | — | — | None | — | — | JP | disclosed |
| EP-4660184-A1 | NAV1.7- AND/OR NAV1.8-INHIBITING HYDROXAMATES, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS | Eurofarma Laboratórios S.A. (BR) | 2025-12-10 | — | — | EP | disclosed |
| EP-3773563-B1 | PRODRUGS OF FUSED-BICYCLIC C5AR ANTAGONISTS | CHEMOCENTRYX INC (US) | 2024-10-16 | — | — | EP | disclosed |
| WO-2024159287-A1 | NAV1.7- AND/OR NAV1.8-INHIBITING HYDROXAMATES, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS | EUROFARMA LABORATÓRIOS S.A. (BR) | 2024-08-08 | — | — | WO | disclosed |
| US-20240131356-A1 | COMBINATION OF INTRACELLULAR AND EXTRACELLULAR PHOTOSENSITIZERS FOR TREATMENT OF BACTERIAL INFECTION | VANDERBILT UNIVERSITY | 2024-04-25 | — | — | US | disclosed |
| WO-2024059471-A2 | SMALL MOLECULAR WEIGHT INHIBITORS OF FORTILIN | UNIVERSITY OF WASHINGTON (US) | 2024-03-21 | — | — | WO | disclosed |
| CN-113039075-B | Rubber composition, vulcanized rubber, and tire | 株式会社普利司通 | 2024-02-06 | — | — | CN | disclosed |
| CN-111954525-B | Prodrugs of fused bicyclic C5aR antagonists | 凯莫森特里克斯股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| EP-4284912-A1 | COMBINATION OF INTRACELLULAR AND EXTRACELLULAR PHOTOSENSITIZERS FOR TREATMENT OF BACTERIAL INFECTION | Vanderbilt University (US) | 2023-12-06 | — | — | EP | disclosed |
| US-5677336-A | ADMINISTERING TO MAMMALS TO MODULATE PROCESSES MEDIATED BY ANDROGEN RECEPTOR | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-10-14 | — | — | US | disclosed |
| US-5561119-A | ANTITUMOR AGENTS | LABORATOIRES HOECHST (FR) | 1996-10-01 | — | — | US | disclosed |
| EP-0537742-B1 | Styrene derivatives | MITSUBISHI CHEM CORP (JP) | 1996-08-21 | — | — | EP | disclosed |
| US-5514711-A | ANTICARCINOGENIC AGENTS; SIDE EFFECT REDUCTION | MITSUBISHI CHEMICAL CORPORATION (JP) | 1996-05-07 | — | — | US | disclosed |
| WO-1995011215-A1 | NON-STEROID ANDROGEN RECEPTOR ANTAGONISTS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1995-04-27 | — | — | WO | disclosed |
| EP-0375457-B1 | Cyclic ether derivatives | ICI PLC (GB) | 1994-03-16 | — | — | EP | disclosed |
| EP-0537742-A2 | Styrene derivatives | Mitsubishi Chemical Corporation (JP) | 1993-04-21 | — | — | EP | disclosed |
| JP-H0377872-A | 2-(2-(2-HYDROXYPHENYL)VINYL)PYRAZINE AND ITS PRODUCTION | SEKISUI CHEM CO LTD | 1991-04-03 | — | — | JP | disclosed |
| EP-0375457-A2 | Cyclic ether derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-06-27 | — | — | EP | disclosed |